Search results
2 Dividend Stocks Billionaires Are Buying: Should You?
Motley Fool via Yahoo Finance· 3 days agoPfizer Pfizer hasn't performed well recently. Despite its important role in developing effective...
FDA Gives Nod to RSV Vaccine for People in Their 50s
US News & World Report· 1 hour agoDrugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults 60 and older, since age brings higher ...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 5 days agoThis new round of cuts will result in Pfizer incurring one-time charges totaling $1.7 billion, the...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 2 days agoThe dividend isn't the only thing attractive about this stock Keith Speights (Pfizer): Income...
Moderna’s flu-COVID combo shot hits goal in late-stage trial - The Boston Globe
The Boston Globe· 1 hour agoModerna said its combination flu and Covid shot met the goals of a pivotal late-stage trial,...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 5 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 3 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 3 days agoGlobal vaccine and drugmaker GSK asked the FDA in February to expand approval beyond adults 60 and...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 3 days agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...